Thursday, April 11, 2019 3:07:37 PM
BICX signs $10 million deep discount death spiral toxic equity financing agreement with notoriously sleazy toxic funder Northbridge Financial Inc.
from the S-1 filed with the SEC by BICX Feb 14, 2019:
https://www.sec.gov/Archives/edgar/data/1443863/000147793219000506/bicx_s1.htm
Northbridge Investment Agreement
On February 9, 2018, the Company entered into the Investment Agreement and a Registration Rights Agreement with Northbridge. Under the terms of the Investment Agreement, Northbridge has agreed to provide the Company with up to ten million dollars ($10,000,000) of funding in the form of purchases of shares of the Company’s Common Stock. A registration statement on Form S-1 registering these future shares was declared effective by the Securities and Exchange Commission (the “SEC”) on September 12, 2018.
The Company has the right to deliver drawdown notices to Northbridge and Northbridge will be obligated to purchase registered shares of the Company’s Common Stock based on the investment amount specified in each drawdown notice. The maximum amount that the Company shall be entitled to draw down in each drawdown notice shall be equal to twice the average of the daily trading volume for the Common Stock during the twelve trading days preceding the drawdown notice date, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the Investment Agreement, Northbridge and its affiliates will not be permitted to purchase and the Company may not deliver drawdown notices to Northbridge that would result in Northbridge’s beneficial ownership totaling more than 4.99% of the outstanding Common Stock. The price of each registered share shall be equal to 80% percent of the average of the three lowest closing prices of the Common Stock during the twelve trading days preceding the date the applicable drawdown notice is delivered to Northbridge.
and the actual agreement included in the above filing exhibits:
https://www.sec.gov/Archives/edgar/data/1443863/000147793218000915/bicx_ex102.htm
from the S-1 filed with the SEC by BICX Feb 14, 2019:
https://www.sec.gov/Archives/edgar/data/1443863/000147793219000506/bicx_s1.htm
Northbridge Investment Agreement
On February 9, 2018, the Company entered into the Investment Agreement and a Registration Rights Agreement with Northbridge. Under the terms of the Investment Agreement, Northbridge has agreed to provide the Company with up to ten million dollars ($10,000,000) of funding in the form of purchases of shares of the Company’s Common Stock. A registration statement on Form S-1 registering these future shares was declared effective by the Securities and Exchange Commission (the “SEC”) on September 12, 2018.
The Company has the right to deliver drawdown notices to Northbridge and Northbridge will be obligated to purchase registered shares of the Company’s Common Stock based on the investment amount specified in each drawdown notice. The maximum amount that the Company shall be entitled to draw down in each drawdown notice shall be equal to twice the average of the daily trading volume for the Common Stock during the twelve trading days preceding the drawdown notice date, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the Investment Agreement, Northbridge and its affiliates will not be permitted to purchase and the Company may not deliver drawdown notices to Northbridge that would result in Northbridge’s beneficial ownership totaling more than 4.99% of the outstanding Common Stock. The price of each registered share shall be equal to 80% percent of the average of the three lowest closing prices of the Common Stock during the twelve trading days preceding the date the applicable drawdown notice is delivered to Northbridge.
and the actual agreement included in the above filing exhibits:
https://www.sec.gov/Archives/edgar/data/1443863/000147793218000915/bicx_ex102.htm
Recent BICX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 07:31:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 07:04:16 PM
- BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for December 11th • GlobeNewswire Inc. • 12/09/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:28:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 05:59:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 08:15:38 PM
